Highlights DBV Technologies S.A. Nasdaq

Equities

DBVT

US23306J1016

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
0.6669 ^USD	-0.46%		-2.21%	-30.01%

Apr. 23	European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	MT
Apr. 22	European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	Apr. 19	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 17	MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	Apr. 12	MT
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading	Apr. 08	MT
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	Apr. 05	MT
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher	Apr. 01	MT
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading	Mar. 25	MT
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday Trading	Mar. 22	MT
European Equities Traded in the US as American Depositary Receipts Ease Wednesday	Mar. 20	MT
DBV Technologies: down sharply, cash flow not reassuring	Mar. 08	CF
DBV Technologies S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Global markets live: BAE Systems, HSBC, Nvidia, Tesla, Boeing...	Feb. 21
DBV Technologies: share price falls as Xolair receives green light in the USA	Feb. 19	CF
DBV Technologies S.A. to Present New Data at ACAAI 2023	Nov. 02	CI
DBV Technologies S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-31	CI
DBV Technologies Says FDA Agrees With Six-Month Duration of Peanut Allergy Patch Study in Toddlers	23-08-01	MT
Dbv Technologies S.A. Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies	23-07-31	CI
DBV Technologies S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-31	CI
DBV Technologies S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-04	CI
DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 - 3 Years After Receiving Pre-BLA Responses from FDA	23-04-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DBV Technologies S.A. Nasdaq

Equities

DBVT

US23306J1016

Highlights

Filters